CKD risk factors | No CKD | CKD (n = 6038) | |
---|---|---|---|
Patients with complete follow-up (n = 156,615) | Patients with incomplete follow-up (n = 172,361) | ||
Hypertensiona | 22,074 (14.1) | 24,971 (14.5) | 3554 (58.9) |
Hypertensive treatmentb | 22,122 (14.1) | 24,769 (14.4) | 3655 (60.5) |
Type 1 diabetes mellitusa | 703 (0.4) | 740 (0.4) | 36 (0.6) |
Type 2 diabetes mellitusa | 5574 (3.6) | 6383 (3.7) | 1221 (20.2) |
History of cardiovascular diseasea | 11,096 (7.1) | 13,407 (7.8) | 2182 (36.1) |
History of heart failurea | 743 (0.5) | 1088 (0.6) | 387 (6.4) |
History of strokea | 1875 (1.2) | 2538 (1.5) | 509 (8.4) |
Peripheral vascular diseasea | 2127 (1.4) | 2532 (1.5) | 331 (5.5) |
Kidney stonesa | 751 (0.5) | 814 (0.5) | 64 (1.1) |
Rheumatoid arthritisa | 1321 (0.8) | 1512 (0.9) | 142 (2.4) |
Systemic lupus erythematosusa | 99 (0.1) | 104 (0.1) | 8 (0.1) |
Family history of kidney diseasea | 25 (0) | 28 (0) | 3 (0) |
NSAID useb | 5101 (3.3) | 5389 (3.1) | 402 (6.7) |
Acute kidney injury in the last 2 years | 1975 (1.3) | 2633 (1.5) | 413 (6.8) |
Prostatic hypertrophya | 967 (0.6) | 1143 (0.7) | 173 (2.9) |
Haematuriaa | 3176 (2) | 3574 (2.1) | 341 (5.6) |
Lithium useb | 150 (0.7) | 219 (0.1) | 52 (0.9) |
Tacrolimus useb | 4 (0) | 5 (0) | 2 (0) |
Cyclosporin useb | 12 (0.1) | 20 (0) | 6 (0.1) |